文献

J-GLOBAL ID：202002222754946817   整理番号：20A0996196

転移性大腸癌患者におけるレゴラフェニブまたはトリフルリジン/チピラシルの生存率向上を評価するための予後スコア:REGOTAS研究の探索的解析

Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study

著者 (25件)： Moriwaki Toshikazu (Division of Gastroenterology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan) ,  Fukuoka Shota (Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan) ,  Masuishi Toshiki (Department of Clinical Oncology, Aichi Cancer Center Hospital, Aichi, Japan) ,  Takashima Atsuo (Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan) ,  Kumekawa Yosuke (Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan) ,  Kajiwara Takeshi (Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Ehime, Japan) ,  Yamazaki Kentaro (Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan) ,  Esaki Taito (Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan) ,  Makiyama Akitaka (Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan) ,  Denda Tadamichi (Division of Gastroenterology, Chiba Cancer Center, Chiba, Japan) ,  Hatachi Yukimasa (Department of Medical Oncology, Kobe City Medical Center General Hospital, Hyogo, Japan) ,  Suto Takeshi (Department of Gastroenterological Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan) ,  Sugimoto Naotoshi (Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan) ,  Enomoto Masanobu (Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University, Tokyo, Japan) ,  Ishikawa Toshiaki (Department of Specialized Surgeries, Tokyo Medical and Dental University, Graduate School of Medicine and Dentistry, Tokyo, Japan) ,  Kashiwada Tomomi (Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan) ,  Oki Eiji (Department Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan) ,  Komatsu Yoshito (Department of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Hokkaido, Japan) ,  Tsuji Akihito (Department of Clinical Oncology, Faculty of Medicine, Kagawa University, Kagawa, Japan) ,  Tsuchihashi Kenji (Department of Medicine and Biosystemic Science, Kyushu University Graduate of Medical Sciences, Fukuoka, Japan) ,  Sakai Daisuke (Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Osaka, Japan) ,  Ueno Hideki (Department of Surgery, National Defense Medical College Hospital, Saitama, Japan) ,  Tamura Takao (Department of Medical Oncology, Kindai University, Faculty of Medicine, Osaka, Japan) ,  Yamashita Kimihiro (Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Hyogo, Japan) ,  Shimada Yasuhiro (Clinical Oncology Division, Kochi Health Sciences Center, Kochi, Japan)
資料名： International Journal of Clinical Oncology (Web)  (International Journal of Clinical Oncology (Web))
巻： 25  号： 4  ページ： 614-621  発行年： 2020年 
JST資料番号： U1599A  ISSN： 1341-9625  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： ドイツ (DEU)  言語： 英語 (EN)

抄録/ポイント： 要約:背景:転移性大腸癌(mCRC)患者において,レゴラフェ...

シソーラス用語： ヒト ,...
準シソーラス用語： Cox比例ハザードモデル ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0996196&from=J-GLOBAL&jstjournalNo=U1599A") }}

著者キーワード (5件)： 大腸癌 ,  予後因子 ,  レゴラafen ,  TAS-102 ,  トリフルリジン/チピラシル

分類 (3件)： 消化器の腫よう  (GH04000D) ,  腫ようの薬物療法  (GE03032C) ,  抗腫よう薬の臨床への応用  (GW16020L)

物質索引 (2件)： トリフルリジン/チピラシル ,  レゴラフェニブ

タイトルに関連する用語 (11件)： 転移性大腸癌 ,  患者 ,  レゴラフェニブ ,  トリフルリジン ,  生存率 ,  評価 ,  予後 ,  スコア ,  研究 ,  探索 ,  解析